APA (7th ed.) Citation

M, L., A, G., J, P., A, Y., F, E., R, F., . . . A, G. (2023). Exploring the Immunogenicity of Noncanonical HLA-I Tumor Ligands Identified through Proteogenomics. Clinical cancer research : an official journal of the American Association for Cancer Research, 29(12), 2250. https://doi.org/10.1158/1078-0432.CCR-22-3298

Chicago Style (17th ed.) Citation

M, Lozano-Rabella, et al. "Exploring the Immunogenicity of Noncanonical HLA-I Tumor Ligands Identified Through Proteogenomics." Clinical Cancer Research : An Official Journal of the American Association for Cancer Research 29, no. 12 (2023): 2250. https://doi.org/10.1158/1078-0432.CCR-22-3298.

MLA (9th ed.) Citation

M, Lozano-Rabella, et al. "Exploring the Immunogenicity of Noncanonical HLA-I Tumor Ligands Identified Through Proteogenomics." Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, vol. 29, no. 12, 2023, p. 2250, https://doi.org/10.1158/1078-0432.CCR-22-3298.